• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.60% Nasdaq Up 0.24%

    Navidea Biopharmaceuticals, Inc (NAVB)

    -NYSE MKT
    1.97 Up 0.18(10.06%) 2:29PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:1.79
    Open:1.77
    Bid:1.95 x 5000
    Ask:1.96 x 600
    1y Target Est:4.31
    Beta:1.51
    Earnings Date:Mar 4 - Mar 9 (Est.)
    Day's Range:1.72 - 1.97
    52wk Range:0.97 - 2.12
    Volume:1,415,464
    Avg Vol (3m):1,137,470
    Market Cap:295.84M
    P/E (ttm):N/A
    EPS (ttm):-0.29
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NAVB

    Comparison

    Symbol% ChgMkt Cap
    NAVBUp 10.06%295.84M
    LLYDown 1.21%76.50B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):58.29
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.24
    Quarterly EPS Est (Dec-14) :-0.05
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback